Astria Therapeutics (ATXS) Earnings Date & Reports

Astria Therapeutics Inc is a biopharmaceutical company engaged to bring life-changing therapies to patients and families affected by rare and niche allergic and immunological diseases... Show more

Industry: #Biotechnology

Get AI intraday signals

A.I. Advisor

published Earnings

ATXS is expected to report earnings to rise 2.18% to -44 cents per share on May 08

Astria Therapeutics ATXS Stock Earnings Reports

Q1'25

Est.

$-0.45

Q4'24

Beat

by $0.01

Q3'24

Est.

$-0.42

Q2'24

Missed

by $0.06

Q1'24

Missed

by $0.03

The last earnings report on March 11 showed earnings per share of -43 cents, beating the estimate of -45 cents. With 243.87K shares outstanding, the current market capitalization sits at 304.74M.

View a ticker or compare two or three

Compare

ATXS